We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Promethean | LSE:PTH | London | Ordinary Share | GB00B08H5G38 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 3.125 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
RNS Number:8990M
PPL Therapeutics PLC
27 June 2003
PPL Therapeutics plc ("the Company")
Application has been made to the London Stock Exchange and to the UK Listing
Authority for the listing of 121,068,834 Ordinary shares of 1p each, ranking
pari passu with the existing Ordinary shares, to the Official List.
118,582,994 shares are being issued in connection with the subdivision of shares
as detailed in the announcement dated 24 June 2003 (RNS Number: 7043M).
The application to list the remaining 2,485,840 shares is being made to carry
forward unissued block listing shares. These shares will be allotted following
the exercise of options under the rules of the following schemes/plans.
1998 Approved Executive Share Option Scheme 785,840
IRS Approved Stock Option Plan 140,000
Company Share Option Plan A 580,000
Company Share Option Plan B Unapproved Scheme 640,000
SAYE Scheme 340,000
Total 2,485,840
This information is provided by RNS
The company news service from the London Stock Exchange
END
LISPUUUCQUPWGAM
1 Year Promethean Chart |
1 Month Promethean Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
